"A Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Oral Fingolimod In Patients with Amyotrophic Lateral Sclerosis (ALS) (P7.067)." Neurology
84.14 Supplement
(2015):
P7.067.
Web. 27 May. 2022.
Advertisement